In 2018, FDA published guidance to 503A pharmacies on what will be considered unauthorized compounding of a product that is essentially a copy of an FDA-approved product, with an exception available when the prescriber documents on the prescription that the compounded drug product produces a significant difference for the identified individual patient. Under the 2018 guidance, FDA generally does not intend to question prescriber determinations that are documented in a prescription or notation. To date, patient-specific GLP-1 compounding activities have often included adding supplemental ingredients to combat side effects of the GLP-1 products or customizing doses, with a significant percentage of prescriptions for customization written by telehealth prescribers
Reference: GLP-1 weight-loss drugs are reshaping modern dating and intimacy - ( Source-Medindia
Egyptian Journal of Neurology, Psychiatry and Neurosurgery
The experience of tiredness can vary considerably between individualssome may notice mild lethargy during the initial weeks of treatment, whilst others may experience more persistent symptoms that affect daily functioning
Venture capital firms including Tiger Global, General Catalyst, Founders Fund, and Silver Lake Partners have poured hundreds of millions into these companies
